Advancements in the development of antivirals against SARS-Coronavirus
Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) caused an outbreak in 2002-2003, spreading to 29 countries with a mortality rate of about 10%. Strict quarantine and infection control methods quickly stopped the spread of the disease. Later research showed that SARS-CoV came from animals (zo...
Saved in:
| Main Authors: | Mrityunjay Kumar, Mirza Sarwar Baig, Kanchan Bhardwaj |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Cellular and Infection Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fcimb.2025.1520811/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Editorial: Exploring SARS-CoV-2 inflammatory responses and potential targets for treatment
by: Kanchan Bhardwaj, et al.
Published: (2025-05-01) -
Novel coronavirus SARS-CoV-2 in the context of global epidemiology of coronavirus infections
by: M. V. Supotnitskiy
Published: (2020-06-01) -
Aerosol and surface persistence: Novel SARS-CoV-2 versus other coronaviruses
by: Kewal Krishan, et al.
Published: (2020-07-01) -
Local antiviral activity of the drug «Thymogen®», nasal dosed spray, against SARS-CoV-2 coronavirus <i>in vitro</i>
by: I. A. Leneva, et al.
Published: (2021-08-01) -
A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses
by: Sin-Yee Fung, et al.
Published: (2020-01-01)